摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(3-甲氧基苯基)丙酸 | 10516-71-9

中文名称
3-(3-甲氧基苯基)丙酸
中文别名
间甲氧基-Β-苯丙酸;3-(3-甲氧基苯基丙酸)
英文名称
3-(3-Methoxy-phenyl)-propionic acid
英文别名
3-(3-methoxyphenyl)propanoic acid;3-methoxydihydrocinnamic acid;3-methoxybenzenepropanoic acid;β-(3-methoxyphenyl)propionic acid;3-(3-Methoxyphenyl)propionic acid
3-(3-甲氧基苯基)丙酸化学式
CAS
10516-71-9
化学式
C10H12O3
mdl
MFCD00014027
分子量
180.203
InChiKey
BJJQJLOZWBZEGA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    43-45 °C (lit.)
  • 沸点:
    318.1±17.0 °C(Predicted)
  • 密度:
    1.144±0.06 g/cm3(Predicted)
  • 溶解度:
    溶于二甲基亚砜
  • 物理描述:
    Solid
  • 稳定性/保质期:

    遵照规格使用和储存则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R36/37/38
  • WGK Germany:
    3
  • 海关编码:
    2918990090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    密封于阴凉干燥处。

SDS

SDS:207f027b947e0d5ddda3f2b6e136d4fa
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3-(3-Methoxyphenyl)propionic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 3-(3-Methoxyphenyl)propionic acid
CAS number: 10516-71-9

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H12O3
Molecular weight: 180.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

生物活性

3-(3-甲氧基苯基)丙酸是一种天然存在的人类代谢物,它是一种有机酸,主要通过尿液排泄。

靶点

Human Endogenous Metabolite(人类内源性代谢物)

化学性质:白色结晶,熔点50-51℃。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6

反应信息

点击查看最新优质反应信息

文献信息

  • Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitors
    作者:Fabian Heider、Francesco Ansideri、Roberta Tesch、Tatu Pantsar、Urs Haun、Eva Döring、Mark Kudolo、Antti Poso、Wolfgang Albrecht、Stefan A. Laufer、Pierre Koch
    DOI:10.1016/j.ejmech.2019.04.035
    日期:2019.8
    Alzheimer's disease. A set of 39 compounds was synthesized and evaluated in kinase activity assays for their ability to inhibit both target kinases. Among the synthesized compounds, potent dual-target-directed inhibitors showing IC50 values down to the low double-digit nanomolar range, were identified. One of the best balanced dual inhibitors presented in here is N-(4-(2-ethyl-4-(4-fluorophenyl)-1H-imidazol
    同时抑制参与同一复杂疾病进展的两个靶标的化合物可能会表现出累加甚至协同的治疗作用。在这里,我们介绍了2,4,5-三取代的咪唑类化合物,作为p38α丝裂原活化蛋白激酶和糖原合酶激酶3β(GSK3β)的双重抑制剂。两种酶都是神经退行性疾病(例如阿尔茨海默氏病)的潜在治疗靶标。合成了39种化合物,并在激酶活性测定中评估了它们抑制两种靶激酶的能力。在合成的化合物中,鉴定出了显示出低至两位数纳摩尔范围低的IC 50值的有效的双靶标抑制剂。这里介绍的最佳平衡双重抑制剂之一是N-(4-(2-乙基-4-(4-氟苯基)-1 H-咪唑-5-基)吡啶-2-基)环丙烷甲酰胺(20c)(p38α,IC 50  = 16 nM;GSK3β,IC 50 = 35 nM)具有优异的代谢稳定性和比密切相关的GSK3α明显的同工型选择性。我们的发现通过基于先前发布的X射线结构的计算机对接研究得到了合理化。
  • Vinylogous carbinolamine tumor inhibitors. 23. Synthesis and antileukemic activity of bis[[(carbamoyl)oxy]methyl]-substituted pyrrolo[2,1-a]isoquinolines, pyrrolo[1,2-a]quinolines, pyrrolo[2,1-a]isobenzazepines, and pyrrolo[1,2-a]benzazepines
    作者:Wayne K. Anderson、Arvela R. Heider、Natarajan Raju、Jeffery A. Yucht
    DOI:10.1021/jm00119a008
    日期:1988.11
    compound or with a mesoionic oxazolone intermediate. All of the bis(carbamates) were active in vivo against P388 lymphocytic leukemia with 5,6-dihydro-8-methoxy-1,2- bis(hydroxymethyl)pyrrolo[2,1-a]isoquinoline bis[N-(2-propyl)carbamate] (3c) showing the highest level of activity.
    通过与合适的Resissert化合物的三氟甲磺酸盐或与中离子的恶唑酮中间体进行1,3-偶极环加成反应,合成了一系列双[[(基甲酰基)氧基]甲基]-取代的吡咯稠合的三环杂环。所有的双(氨基甲酸酯)在体内均具有5,6-二氢-8-甲氧基-1,2-双(羟甲基)吡咯并[2,1-a]异喹啉双[N-(2-)对P388淋巴细胞性白血病的活性。丙基]氨基甲酸酯](3c)表现出最高的活性平。
  • Generation of Phosphoranyl Radicals via Photoredox Catalysis Enables Voltage–Independent Activation of Strong C–O Bonds
    作者:Erin E. Stache、Alyssa B. Ertel、Tomislav Rovis、Abigail G. Doyle
    DOI:10.1021/acscatal.8b03592
    日期:2018.12.7
    oxygen-centered nucleophile. We show the desired reactivity in the reduction of benzylic alcohols to the corresponding benzyl radicals with terminal H atom trapping to afford the deoxygenated products. Using the same method, we demonstrate access to synthetically versatile acyl radicals, which enables the reduction of aromatic and aliphatic carboxylic acids to the corresponding aldehydes with exceptional chemoselectivity
    尽管醇和羧酸作为有机分子中的官能团盛行,并且有可能用作自由基前体,但C-O键仍然难以激活。我们报告了通过光氧化还原催化直接从这些普遍存在的官能团同时进入烷基和酰基自由基的合成策略。该方法利用了磷化氢自由基的独特反应性,该反应是由膦自由基阳离子和以氧为中心的亲核试剂之间的极性/ SET交叉产生的。我们显示了在末端醇被俘获以提供脱氧产物的情况下,将苄醇还原为相应的苄基所需要的反应性。使用相同的方法,我们演示了合成通用的酰基自由基的获得方法,可以将芳香族和脂肪族羧酸还原为相应的醛,并具有出色的化学选择性。该协议还通过分子内酰基自由基环化将羧酸转化为杂环和环状酮,从而一步一步形成C–O,C–N和C–C键。
  • A Biocompatible Alkene Hydrogenation Merges Organic Synthesis with Microbial Metabolism
    作者:Gopal Sirasani、Liuchuan Tong、Emily P. Balskus
    DOI:10.1002/anie.201403148
    日期:2014.7.21
    Organic chemists and metabolic engineers use orthogonal technologies to construct essential small molecules such as pharmaceuticals and commodity chemicals. While chemists have leveraged the unique capabilities of biological catalysts for small‐molecule production, metabolic engineers have not likewise integrated reactions from organic synthesis with the metabolism of living organisms. Reported herein
    有机化学家和代谢工程师使用正交技术构建必要的小分子,如药物和商品化学品。虽然化学家利用生物催化剂的独特能力生产小分子,但代谢工程师还没有将有机合成的反应与生物体的代谢相结合。本文报道了一种利用催化剂和由活微生物直接产生的氢气进行烯烃加氢的方法。这种生物相容性转化需要催化剂和微生物,并且可以在制备规模上使用,代表了一种结合有机化学和代谢工程的化学合成新策略。
  • Cobalt‐Catalyzed Deoxygenative Hydroboration of Nitro Compounds and Applications to One‐Pot Synthesis of Aldimines and Amides
    作者:Kristina A. Gudun、Raikhan Zakarina、Medet Segizbayev、Davit Hayrapetyan、Ainur Slamova、Andrey Y. Khalimon
    DOI:10.1002/adsc.202101043
    日期:2022.2
    The commercially available and bench-stable Co(acac)2 ligated with bis[(2-diphenylphosphino)phenyl] ether (dpephos) was employed for selective room temperature hydroboration of nitro compounds with HBPin (TOF up to 4615 h−1), tolerating halide, hydroxy, amino, ether, ester, lactone, amide and heteroaromatic functionalities. These reactions offered a direct access to a variety of N-borylamines RN(H)BPin
    使用与双[(2-二苯基膦基)苯基]醚 (dpephos) 连接的可商购且台式稳定的 Co(acac) 2与 HBPin 选择性室温氢化硝基化合物(TOF 高达 4615 h -1),耐受卤化物、羟基、基、醚、酯、内酯、酰胺和杂芳族官能团。这些反应提供了直接获得各种原位N-胺 RN(H)BPin的途径用醛和羧酸处理产生一系列醛亚胺和仲羧酰胺,而不需要脱和/或偶联剂。以顺序一锅法将这些转化结合起来,可以从容易获得且廉价的硝基化合物直接和选择性地合成醛亚胺和仲羧酰胺。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台